2024-01-01 2024-12-31 false Capium Accounts Production 1.1 08895770 2024-01-01 2024-12-31 08895770 bus:AbridgedAccounts 2024-01-01 2024-12-31 08895770 bus:FRS102 2024-01-01 2024-12-31 08895770 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 08895770 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08895770 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08895770 2024-01-01 2024-12-31 08895770 2024-12-31 08895770 bus:RegisteredOffice 2024-01-01 2024-12-31 08895770 core:WithinOneYear 2024-12-31 08895770 core:AfterOneYear 2024-12-31 08895770 1 2024-01-01 2024-12-31 08895770 bus:Director1 2024-01-01 2024-12-31 08895770 bus:Director1 2024-12-31 08895770 bus:Director1 2023-01-01 2023-12-31 08895770 bus:Director2 2024-01-01 2024-12-31 08895770 bus:Director2 2024-12-31 08895770 bus:Director2 2023-01-01 2023-12-31 08895770 2023-01-01 08895770 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 08895770 2023-01-01 2023-12-31 08895770 2023-12-31 08895770 core:WithinOneYear 2023-12-31 08895770 core:AfterOneYear 2023-12-31 08895770 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 08895770 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 08895770 bus:OrdinaryShareClass1 2024-12-31 08895770 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 08895770 bus:OrdinaryShareClass1 2023-12-31 08895770 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 08895770 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 08895770 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 08895770 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 08895770 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 08895770 core:Non-currentFinancialInstruments 2024-12-31 08895770 core:Non-currentFinancialInstruments 2023-12-31 08895770 core:ShareCapital 2024-12-31 08895770 core:ShareCapital 2023-12-31 08895770 core:RetainedEarningsAccumulatedLosses 2024-12-31 08895770 core:RetainedEarningsAccumulatedLosses 2023-12-31 08895770 dpl:Item1 2024-01-01 08895770 dpl:Item1 2024-12-31 08895770 dpl:Item1 2023-01-01 08895770 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 08895770


 

 

 

PHARMACEUTICAL MANAGEMENT SERVICES LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
 
 
Notes
 
2024
£
  2023
£
Current assets      
Debtors 15,251   
Cash at bank and in hand 3,132    11,523 
18,383    11,523 
Creditors: amount falling due within one year (2,749)   (4,712)
Net current assets 15,634    6,811 
 
Total assets less current liabilities 15,634    6,811 
Creditors: amount falling due after more than one year (1,079)   (1,951)
Net assets 14,555    4,860 
 

Capital and reserves
     
Called up share capital 3 100    2 
Profit and loss account 14,455    4,858 
Shareholders' funds 14,555    4,860 
 


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 15 May 2025 and were signed on its behalf by:


-------------------------------
Mr Imraan Khan
Director
1
General Information
Pharmaceutical Management Services Limited is a private company, limited by shares, registered in , registration number 08895770, registration address 22 Kinloch Drive, Bolton, BL1 4LZ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
2.

Average number of employees

Average number of employees during the year was 2 (2023 : 2).
3.

Share Capital

Authorised
100 Class A shares of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

2